Patrick Lin
Net Worth

Last updated:

What is Patrick Lin net worth?

The estimated net worth of Mr. Patrick Lin is at least $486,593 as of 1 Feb 2024. He owns shares worth $5,693 as insider and has received compensation worth at least $480,900 in Processa Pharmaceuticals, Inc..

What is the salary of Patrick Lin?

Mr. Patrick Lin salary is $96,180 per year as Co-Founder, Chief Bus. & Strategy Officer in Processa Pharmaceuticals, Inc..

How old is Patrick Lin?

Mr. Patrick Lin is 60 years old, born in 1965.

What stocks does Patrick Lin currently own?

As insider, Mr. Patrick Lin owns shares in one company:

Company Title Shares Price per share Total value
Processa Pharmaceuticals, Inc. (PCSA) Co-Founder, Chief Bus. & Strategy Officer 27,478 $0.21 $5,693

What does Processa Pharmaceuticals, Inc. do?

Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosis lipoidica, a chronic disfiguring condition. The company is also developing PCS12852, a novel selective 5-hydroxytryptamine 4 (5-HT4) receptor agonist that is in Phase 2A clinical trials for the treatment of gastroparesis, chronic constipation, constipation-predominant irritable bowel syndrome, and functional dyspepsia; PCS3117, a cytosine analog, which is in Phase 2B clinical trials for the treatment of pancreatic and non-small cell lung cancer; and PCS6422, an oral, potent, selective, and irreversible inhibitor of dihydropyrimidine dehydrogenase that is in Phase 1B clinical trials for treating metastatic colorectal and breast cancer. In addition, it develops PCS11T, an analog of SN38 and irinotecan drug for the treatment of various cancers. The company was incorporated in 2011 and is based in Hanover, Maryland.

PCSA logo
PCSA
Processa Pharmaceuticals, Inc.
$0.21

Patrick Lin insider trading

Processa Pharmaceuticals, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 1,500 $2.4 $3,600
Purchase
Common Stock 2,500 $2.37 $5,925
Option
Common Stock 7,601 N/A N/A
Purchase
Common Stock 2,000 $1.6 $3,190
Purchase
Common Stock 800 $3.54 $2,835
Purchase
Common Stock 1,200 $3.13 $3,752
Purchase
Common Stock 3,000 $4 $12,000
Purchase
Common Stock 3,500 $4.8 $16,797
Purchase
Common Stock 4,000 $6.02 $24,088
Purchase
Common Stock 2,000 $6.65 $13,300
Purchase
Common Stock 31,250 N/A N/A

Processa Pharmaceuticals key executives

Processa Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: